This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abbexa
product type :
antibody
product name :
N-Acetylaspartate Synthetase (Nat8l) Antibody
catalog :
abx431860
quantity :
200 µl
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, ELISA
product information
Catalogue Code :
abx431860
Target :
N-Acetylaspartate Synthetase (Nat8l)
Product Name :
N-Acetylaspartate Synthetase (Nat8l) Antibody
Short Name :
Nat8l
Category :
Primary Antibodies
Host :
Goat
Clonality :
Polyclonal
Conjugation :
Unconjugated
Isotype :
IgG
Size 1 :
200 µl
Description :
Nat8l Antibody is a Goat Polyclonal antibody against Nat8l.
Gene Symbol :
NAT8L
NCBI Accession :
NP_001001985.3
Purification :
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide
Buffer :
Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin.
Concentration :
0.5 mg/ml
Tested Applications :
P-ELISA, WB
Storage :
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Form :
Liquid
UNSPSC Code :
12352203
Availability :
Shipped within 5-10 working days.
DryIce :
No
company information
Abbexa
Abbexa LTD, Cambridge, UK
Abbexa LLC, Houston, USA
Abbexa LLC, Houston, USA
info@abbexa.com
https://www.abbexa.com44 (0)1223 75595
1 832 327 7413
1 832 327 7413
headquarters: UK
Abbexa is a biotechnology company based in Cambridge, UK, specializing in high quality, reliable research reagents for scientific research. We work in partnership with academic institutions, hospitals and laboratories across the world to bring an integrated source of antibodies, proteins, ELISA kits and other biological reagents. We are dedicated to providing excellent customer service, quality and affordable products to enable scientists to do better science. For more information, please visit http://www.abbexa.com/.
questions and comments